These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4896482)

  • 1. The use of intravenous tyramine and the cold pressor test to help elucidate a possible mechanism of action of a new isoquinoline compound shown to have antihypertensive properties in humans.
    Pocelinko R; Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):13-9. PubMed ID: 4896482
    [No Abstract]   [Full Text] [Related]  

  • 2. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of debrisoquin, guanethidine and tyramine on platelet function and blood coagulation.
    Zbinden G; Tomlin S
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):153-69. PubMed ID: 5350778
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological actions of N-(2-o-methoxyphenoxyethyl)-6,7-dimethoxy-3,4-dihydro-2-(1H)-isoquinoline carboxamidine hydrobromide (SC-3123).
    Ferrini R; Miragoli G; Santarelli G
    Boll Chim Farm; 1972 Jun; 111(6):353-65. PubMed ID: 4403255
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry.
    Malmors T; Abrams WB
    J Pharmacol Exp Ther; 1970 Jul; 174(1):99-110. PubMed ID: 4316536
    [No Abstract]   [Full Text] [Related]  

  • 6. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs.
    Mitchell JR; Oates JA
    J Pharmacol Exp Ther; 1970 Mar; 172(1):100-7. PubMed ID: 5416937
    [No Abstract]   [Full Text] [Related]  

  • 7. Adaptive changes in the sympathetic nervous system and some effector organs of the rat following long term exercise or cold acclimation and the role of cardiac sympathetic nerves in the genesis of compensatory cardiac hypertrophy.
    Ostman-Smith I
    Acta Physiol Scand Suppl; 1979; 477():1-118. PubMed ID: 296869
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of thyroid and sympathetic nervous system interrelationships. II. Effects of guanethidine on manifestations of hyperthyroidism.
    LEE WY; BRONSKY D; WALDSTEIN SS
    J Clin Endocrinol Metab; 1962 Sep; 22():879-85. PubMed ID: 14463583
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interference of demethylimipramine with the adrenergic action of tyramine, alpha-methyl-M-tyramine and aramine].
    Gessa GL; Vargiu L; Crabai F
    Arch Ital Sci Farmacol; 1965; 15(3):128-33. PubMed ID: 5896314
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of various hypotensive agents on urinary excretion of catecholamines and vanilmandelic acid].
    Woyda J; Gryglewska I
    Pol Tyg Lek; 1973 Jul; 28(30):1141-4. PubMed ID: 4732709
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of action of guanethidine.
    KADZIELAWA K
    Br J Pharmacol Chemother; 1962 Aug; 19(1):74-84. PubMed ID: 14453004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
    Horst WD; Gattanell P
    Biochem Pharmacol; 1970 Jul; 19(7):2335-41. PubMed ID: 5520376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities and limitations in the diagnosis of pheochromocytoma].
    Lachhein L; Schütz J
    Z Gesamte Inn Med; 1969 May; 24(9):257-62. PubMed ID: 4898355
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration.
    Jacob G; Costa F; Vincent S; Robertson D; Biaggioni I
    Circulation; 2003 May; 107(19):2475-9. PubMed ID: 12707242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive and noradrenaline-depleting effect of alpha methyl tyramine and alpha methyl octapamine in the rat].
    Maître L; Brunner H
    Biochem Pharmacol; 1971 Feb; 20(2):351-9. PubMed ID: 5150136
    [No Abstract]   [Full Text] [Related]  

  • 17. Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.
    Mitchell JR; Cavanaugh JH; Arias L; Oates JA
    J Clin Invest; 1970 Aug; 49(8):1596-604. PubMed ID: 5431666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical measurement of the function of the adrenal medulla and sympathetic system in the clinic].
    Jéquier E
    Schweiz Med Wochenschr; 1970 Mar; 100(12):532-6. PubMed ID: 4906883
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure.
    Scriven AJ; Brown MJ; Murphy MB; Dollery CT
    J Cardiovasc Pharmacol; 1984; 6(5):954-60. PubMed ID: 6209506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.